JP2012515551A5 - - Google Patents

Download PDF

Info

Publication number
JP2012515551A5
JP2012515551A5 JP2011548095A JP2011548095A JP2012515551A5 JP 2012515551 A5 JP2012515551 A5 JP 2012515551A5 JP 2011548095 A JP2011548095 A JP 2011548095A JP 2011548095 A JP2011548095 A JP 2011548095A JP 2012515551 A5 JP2012515551 A5 JP 2012515551A5
Authority
JP
Japan
Prior art keywords
antibody
stx2
seq
fragment
polypeptide
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2011548095A
Other languages
English (en)
Japanese (ja)
Other versions
JP5773886B2 (ja
JP2012515551A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2010/021610 external-priority patent/WO2010085539A1/en
Publication of JP2012515551A publication Critical patent/JP2012515551A/ja
Publication of JP2012515551A5 publication Critical patent/JP2012515551A5/ja
Application granted granted Critical
Publication of JP5773886B2 publication Critical patent/JP5773886B2/ja
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2011548095A 2009-01-23 2010-01-21 志賀毒素タイプ2タンパク質に基づいた方法と組成物 Expired - Fee Related JP5773886B2 (ja)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US14689209P 2009-01-23 2009-01-23
US61/146,892 2009-01-23
US21008209P 2009-03-13 2009-03-13
US61/210,082 2009-03-13
PCT/US2010/021610 WO2010085539A1 (en) 2009-01-23 2010-01-21 Methods and compositions based on shiga toxin type 2 protein

Publications (3)

Publication Number Publication Date
JP2012515551A JP2012515551A (ja) 2012-07-12
JP2012515551A5 true JP2012515551A5 (enExample) 2013-03-07
JP5773886B2 JP5773886B2 (ja) 2015-09-02

Family

ID=42356196

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2011548095A Expired - Fee Related JP5773886B2 (ja) 2009-01-23 2010-01-21 志賀毒素タイプ2タンパク質に基づいた方法と組成物

Country Status (16)

Country Link
US (2) US8969529B2 (enExample)
EP (1) EP2381954B8 (enExample)
JP (1) JP5773886B2 (enExample)
KR (1) KR101832499B1 (enExample)
CN (1) CN102292098A (enExample)
AR (1) AR075047A1 (enExample)
AU (1) AU2010206800B2 (enExample)
BR (1) BRPI1007230B1 (enExample)
CA (1) CA2748873C (enExample)
CL (1) CL2011001769A1 (enExample)
ES (1) ES2614803T3 (enExample)
MX (1) MX2011007866A (enExample)
NZ (1) NZ593926A (enExample)
PE (1) PE20120425A1 (enExample)
RU (1) RU2011126896A (enExample)
WO (1) WO2010085539A1 (enExample)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1229045A1 (en) * 2001-02-01 2002-08-07 Institut Curie Universal carrier for targeting molecules to Gb3 receptor expressing cells
AU2007240614B2 (en) 2006-04-20 2013-09-12 The Henry M. Jackson Foundation For The Advancement Of Military Medicine Incorporated Methods and compositions based on Shiga toxin type 1 protein
US8969529B2 (en) 2009-01-23 2015-03-03 The Henry M. Jackson Foundation For The Advancement Of Military Medicine, Inc. Methods and compositions based on shiga toxin type 2 protein
US9513287B1 (en) * 2012-09-28 2016-12-06 The United States Of America, As Represented By The Secretary Of Agriculture High affinity monoclonal antibodies for detection of shiga toxin 2
US9310368B1 (en) * 2012-09-28 2016-04-12 The United States Of America, As Represented By The Secretary Of Agriculture High affinity monoclonal antibodies for detection of Shiga toxin 2 (STX2)
CN111363047A (zh) * 2013-03-12 2020-07-03 分子模板公司 用于引起细胞内化的cd20结合免疫毒素及其使用方法
CN103343164B (zh) * 2013-06-17 2016-05-18 武汉轻工大学 产志贺毒素大肠杆菌多重pcr检测方法、试剂盒及应用
RU2573924C2 (ru) * 2013-07-11 2016-01-27 Федеральное Государственное Бюджетное Учреждение Науки Институт Молекулярной Биологии Им. В.А. Энгельгардта Российской Академии Наук (Имб Ран) НЕТОКСИЧНЫЙ РЕКОМБИНАНТНЫЙ ШИГА ТОКСИН 2-ГО ТИПА (Stx2)
ES2749862T3 (es) * 2014-01-27 2020-03-24 Molecular Templates Inc Polipéptidos efectores desinmunizados de subunidad A de toxina Shiga para aplicaciones en mamíferos
US11142584B2 (en) 2014-03-11 2021-10-12 Molecular Templates, Inc. CD20-binding proteins comprising Shiga toxin A subunit effector regions for inducing cellular internalization and methods using same
KR102496206B1 (ko) * 2014-06-11 2023-02-06 몰레큘러 템플레이츠, 인코퍼레이션. 프로테아제-절단 저항성의 시가 독소 a 서브유닛 작동체 폴리펩티드 및 이를 포함하는 세포-표적화 분자
CN104558167B (zh) * 2014-12-26 2017-12-26 江苏省疾病预防控制中心 检测i型志贺毒素双抗夹心法酶联免疫试剂盒及其应用
WO2016126950A1 (en) 2015-02-05 2016-08-11 Molecular Templates, Inc. Multivalent cd20-binding molecules comprising shiga toxin a subunit effector regions and enriched compositions thereof
US10676723B2 (en) 2015-05-11 2020-06-09 David Gordon Bermudes Chimeric protein toxins for expression by therapeutic bacteria
CN114656573B (zh) 2015-05-30 2024-09-27 分子模板公司 去免疫化的志贺毒素a亚基支架和包含它们的细胞靶向分子
US11129906B1 (en) 2016-12-07 2021-09-28 David Gordon Bermudes Chimeric protein toxins for expression by therapeutic bacteria
MX2019006656A (es) 2016-12-07 2019-09-09 Molecular Templates Inc Polipeptidos efectores de la sub-unidad a de la toxina shiga andamiajes de los efectores de la toxina shiga y moleculas con direccion hacia las celulas para la conjugacion especifica del sitio.
KR102590672B1 (ko) 2017-01-25 2023-10-18 몰레큘러 템플레이츠, 인코퍼레이션. 탈면역된 시가 독소 a 서브유닛 이펙터 및 cd8+ t-세포 에피토프를 포함하는 세포-표적화 분자
KR20200143634A (ko) 2018-04-17 2020-12-24 몰레큘러 템플레이츠, 인코퍼레이션. 탈면역된 시가 독소 a 서브유닛 스캐폴드를 포함하는 her2-표적화 분자
CN115856296B (zh) * 2022-12-16 2023-07-25 华北理工大学 抗志贺氏菌的单克隆抗体及其检测中的应用
CN120647752B (zh) * 2025-08-19 2025-10-28 中国人民解放军军事科学院军事医学研究院 一种抗ⅱ型志贺毒素的单克隆抗体及其相关产品和应用

Family Cites Families (28)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8607679D0 (en) 1986-03-27 1986-04-30 Winter G P Recombinant dna product
US5164298A (en) 1988-06-24 1992-11-17 Hsc Research Development Corporation Verocytotoxin receptor assay
US6255458B1 (en) 1990-08-29 2001-07-03 Genpharm International High affinity human antibodies and human antibodies against digoxin
WO1994004679A1 (en) 1991-06-14 1994-03-03 Genentech, Inc. Method for making humanized antibodies
CA2078539C (en) 1991-09-18 2005-08-02 Kenya Shitara Process for producing humanized chimera antibody
US5552144A (en) * 1992-01-22 1996-09-03 Microcarb, Inc. Immunogenic shiga-like toxin II variant mutants
US5747272A (en) 1994-02-14 1998-05-05 Henry M. Jackson Foundation For The Advancement Of Military Medicine Detection of shiga-like toxins of enterohemoragic Escherichia coli
US5968894A (en) 1994-02-22 1999-10-19 Lingwood; Clifford A. Verotoxin pharmaceutical compositions and medical treatments therewith
CA2265887A1 (en) 1996-09-10 1998-03-19 Henry M. Jackson Foundation For The Advancement Of Military Medicine Histidine-tagged shiga toxins, toxoids, and protein fusions with such toxins and toxoids, methods for the purification and preparation thereof
WO1998020903A1 (en) 1996-11-15 1998-05-22 Trustees Of Tufts College Humanized neutralizing antibodies against hemolytic uremic syndrome
US7910096B2 (en) 1996-11-15 2011-03-22 Trustees Of Tufts College Human neutralizing antibodies against hemolytic uremic syndrome
US20020160005A1 (en) * 1996-11-15 2002-10-31 Trustees Of Tufts College Human neutralizing antibodies against hemolytic urmec syndrome
US20030170248A1 (en) 1997-12-23 2003-09-11 Jeffrey R. Stinson Humanized monoclonal antibodies that protect against shiga toxin induced disease
DK1079856T3 (da) 1998-05-20 2006-12-04 Teijin Ltd Humaniserede antistoffer til genkendelse af verotoxin II samt cellelinie til produktion af samme
DE602004032143D1 (de) * 2003-07-21 2011-05-19 Intervet Int Bv Hybrid-toxine mit shiga-artigen toxin-untereinheiten, verbunden mit escherichia coli wärmeinstabilen enterotoxin-untereinheiten und vakzine daraus
JP5618453B2 (ja) 2003-11-28 2014-11-05 ナショナル リサーチ カウンシル オブ カナダ 抗癌抗体およびその使用
CA2555306A1 (en) 2004-02-06 2005-08-18 Nymox Corporation Humanized antibody
CA2458084A1 (en) 2004-03-12 2005-09-12 Dalton Chemical Laboratories Inc. Novel process for octreotide synthesis
WO2006091677A1 (en) * 2005-02-22 2006-08-31 Jean Gariepy Yeast strains expressing ribosome-inactivating protein domain and method of using same
EP1991565B1 (en) 2006-02-16 2015-01-21 The Henry M. Jackson Foundation for the Advancement of Military Medicine, Inc. Shiga toxoid chimeric proteins
AU2007240614B2 (en) 2006-04-20 2013-09-12 The Henry M. Jackson Foundation For The Advancement Of Military Medicine Incorporated Methods and compositions based on Shiga toxin type 1 protein
AU2007254950A1 (en) 2006-05-31 2007-12-13 Thallion Pharmaceuticals Incorporated Methods, compositions, and kits for treating Shiga toxin associated conditions
US20090258010A1 (en) 2006-05-31 2009-10-15 Thallion Pharmaceuticals, Inc. Methods, compositions, and kits for treating shiga toxin associated conditions
JP4954293B2 (ja) 2006-12-29 2012-06-13 オスプレイ・ファーマシューティカルズ・ユーエスエイ・インコーポレイテッド 改変毒素を選択および生産する方法、改変毒素を含む複合体、およびそれらの使用
US20100298238A1 (en) * 2007-10-08 2010-11-25 Rutgers, The State University Nontoxic shiga-like toxin mutant compositions and methods
CN101314616B (zh) * 2008-05-30 2011-05-11 中国人民解放军第三军医大学 肠出血性大肠杆菌o157:h7志贺毒素ⅱb表位肽及其应用
CA2736877A1 (en) * 2008-09-12 2010-03-18 Scarab Genomics, Llc Clean genome bactofection
US8969529B2 (en) 2009-01-23 2015-03-03 The Henry M. Jackson Foundation For The Advancement Of Military Medicine, Inc. Methods and compositions based on shiga toxin type 2 protein

Similar Documents

Publication Publication Date Title
RU2011126896A (ru) Композиция и полипептид для стимулирования иммунологической реакции на шига токсин 2 типа
JP2009536818A5 (enExample)
JP6643454B2 (ja) Mdr大腸菌特異的抗体
CN102365097A (zh) 艰难梭菌毒素的抗体
EP1855717A1 (en) Surface-located streptococcus pneumoniae polypeptides
CN114729033A (zh) 抗α-溶血素的抗体及其应用
WO2016155605A1 (zh) 肺炎链球菌蛋白抗原及其制备方法和应用
WO2016154491A1 (en) Binding moieties for biofilm remediation
AU2008272087B2 (en) Pseudomonas aeruginosa outer membrane protein PA4710
CN103819557A (zh) 一种阪崎肠杆菌OmpA多克隆抗体及其制备方法与应用
CN101454446A (zh) 绿脓杆菌的外膜蛋白pa0427
EP2528939B1 (en) Recombinant proteins for use in vaccine, antibodies against said proteins, and diagnostic and therapeutic methods including the same
ES2358804T3 (es) Polipéptidos de campylobacter jejuni ubicados en superficie.
CN103319593B (zh) 一种抗StxII单克隆抗体
CN103724413A (zh) 旋毛虫副肌球蛋白b细胞抗原表位8a1及其应用
Tiels et al. Monoclonal antibodies reveal a weak interaction between the F18 fimbrial adhesin FedF and the major subunit FedA
Li et al. Mimotopes selected with a neutralizing antibody against urease B from Helicobacter pylori induce enzyme inhibitory antibodies in mice upon vaccination
CN111948387B (zh) 结核分枝杆菌抗原蛋白Rv1485在制备结核疫苗中的应用
CN108484765B (zh) 一种抗人α-防御素-1单克隆抗体及其应用
Meinke et al. Immunological fingerprinting of group B streptococci: from circulating human antibodies to protective antigens
CN116120410A (zh) 一种结核分枝杆菌蛋白多肽及其应用
CN100467485C (zh) Sars冠状病毒相关多肽及其应用
KR20120113580A (ko) 비브리오 패혈증균 알티엑스에이원에 특이적인 단일클론항체, 이를 분비하는 하이브리도마 및 이를 포함하는 진단키트
CN112851770A (zh) 一种用于诊断或防治金黄色葡萄球菌感染的α溶血素抗原表位肽及其应用
JP4397523B2 (ja) シゲラ様トキシンのエピトープならびにワクチンとしてのおよび診断におけるその使用